Member Article

Acquisition for translation specialists group

RWS Holdings, which owns Alnwick’s Eclipse Translations has acquired an Oxfordshire translation business for £2.3m.

PharmaQuest Limited specialises in providing translation and linguistic validation of patient reports from global clinical trials, and is believed to be the only company worldwide with such a specialism.

Andrew Brode, Executive Chairman of RWS commented: “We are pleased to have acquired PharmaQuest, whose progress we have monitored for several years. It is an attractive business with excellent margins and good growth prospects in a rapidly expanding, specialist sector.

“It will immediately enhance RWS Group earnings and further strengthen our position as a leading provider of commercial and medical translations.

“We look forward to growing PharmaQuest, with the benefit of the Group’s infrastructure and marketing resources, and to broadening our market share in the medical and pharmaceutical industries.”

PharmaQuest’s financial statements for the year ended March 31 showed turnover of £1.4m and adjusted profit before tax of £600,000.

This was posted in Bdaily's Members' News section by Tom Keighley .